Manipal Health Enterprises (NSE:MANIPALHOS) Total Long-Term Assets: ₹207,555 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MANIPALHOS Manipal Health Enterprises Ltd NSE:MANIPALHOS
13 GF Score
Price ₹771.65
! 1 Warning Sign
View Full Analysis

What is Manipal Health Enterprises Total Long-Term Assets?

Manipal Health Enterprises NSE:MANIPALHOS -3.30% 13 Total Long-Term Assets is ₹207,555 Mil as of Mar. 2026. GuruFocus rates NSE:MANIPALHOS with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Manipal Health Enterprises's Total Long-Term Assets for the quarter that ended in Mar. 2026 was ₹207,555 Mil.

Manipal Health Enterprises Total Long-Term Assets Related Terms

Manipal Health Enterprises Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Manipal Health Enterprises's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manipal Health Enterprises Total Long-Term Assets Chart

Manipal Health Enterprises Annual Data
Trend Mar24 Mar25 Mar26
Total Long-Term Assets
87,608.81 173,905.45 207,555.07

Manipal Health Enterprises Semi-Annual Data
Mar24 Mar25 Mar26
Total Long-Term Assets 87,608.81 173,905.45 207,555.07
NSE:MANIPALHOS
13GF Score
Manipal Health Enterprises Ltd NSE:MANIPALHOS
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Manipal Health Enterprises Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of ₹207,555 Mil mean?
Manipal Health Enterprises (NSE:MANIPALHOS) has a Total Long-Term Assets of ₹207,555 Mil as of Mar. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Manipal Health Enterprises and its competitors.
Is Manipal Health Enterprises' Total Long-Term Assets too high?
Manipal Health Enterprises' current Total Long-Term Assets is ₹207,555 Mil. Overall, Manipal Health Enterprises has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Manipal Health Enterprises' Total Long-Term Assets compare to HCA and THC?
Manipal Health Enterprises' Total Long-Term Assets of ₹207,555 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Healthcare Providers & Services company?
A good Total Long-Term Assets depends on the Healthcare Providers & Services industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Manipal Health Enterprises and its competitors. Manipal Health Enterprises's current Total Long-Term Assets is ₹207,555 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manipal Health Enterprises stock overvalued right now?
Manipal Health Enterprises (NSE:MANIPALHOS) has a current Total Long-Term Assets of ₹207,555 Mil. The current Total Long-Term Assets is ₹207,555 Mil. Manipal Health Enterprises' overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Manipal Health Enterprises (NSE:MANIPALHOS), the current Total Long-Term Assets is ₹207,555 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Manipal Health Enterprises Business Description

Other Exchanges 544847:India
Address HAL Airport Road, Rustom Bagh road, The Annexe, no. 98/2, Bengaluru, KA, IND, 560 017
Manipal Health Enterprises Ltd is engaged in the business of running/managing hospitals and providing healthcare services. The company operates through various Hospitals/clinics providing Healthcare services and diagnostic centres in India. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences. It has a single business segment, namely engaged in the business of healthcare services. The company generates revenue by providing inpatient care at its hospitals.
13GF Score

Get the complete analysis for NSE:MANIPALHOS

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹771.65
Price